Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Therapeutics × Other × Clear all

Phase

Phase NA 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2 Other solid neoplasm 1 Other 1 Gastrointestinal 1

Conditions

Obesity 1 Nutrition Disorders 1 Neoplasms 1 Motor Activity 1 Hypertension 1 Diabetes Mellitus 1 Depression 1 Cardiovascular Diseases 1

Interventions

Radiotherapy 3 Cisplatin 2 glucarpidase 1 apraglutide 1 Therapeutics 1 Surveys and Questionnaires 1 Quercetin 1 Methotrexate 1 Leucovorin 1 Hydroxychloroquine 1 Fibroblast Growth Factor 7 1 Fentanyl 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03443635 2022-04-29

CHOP

Tulane University

Phase 1/2 Completed

7,192 enrolled 7 charts

Cardiovascular Diseases, Depression, Diabetes Mellitus, Hypertension, Motor Activity, Neoplasms, Nutrition Disorders, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡